NASDAQ · STOCK
Merck & Co.
$130.21
52W $77.53 – $135.05
57/100
$321.62B
36.6
0.20
Is MRK Bullish or Bearish?
Mixed.
Innellis AI committee rates Merck & Co. (MRK) Watch with a composite score of 57/100
, based on 6 analysts with 50% agreement.
Last updated August 01, 2026.
What Would Change This View
- Upgrade to Buy
- Requires a committee score of 60.0 — +3.00 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Reduce
- Requires the score to fall below 40.0 — -17.00 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull & Bear Case
Bull Case
- ROE of 17.9% shows genuine earnings power backing the valuation — Value
- Dividend yield of 2.6% pays you to wait — Value
- 4 consecutive earnings beats -- consistent execution — Growth
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
- Trend and market structure agree -- coherent bullish picture — Technical
Bear Case
- P/E of 36.0 is moderate-to-rich — Value
- Price-to-book of 5.0x prices in significant intangible value — Value
- EPS declining -48.3% YoY despite any revenue growth — Growth
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of August 01, 2026
Overall Committee Score
57/100
Agreement
50%
Analysts
6
Conviction
Contested
Sector Rank
Top 51%
of 93 Healthcare peers
Value Analyst
neutral
48
/ 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
+ ROE of 17.9% shows genuine earnings power backing the valuation
− P/E of 36.0 is moderate-to-rich
Growth Analyst
neutral
44
/ 100 · High confidence
Moderate growth -- present but not remarkable
+ 4 consecutive earnings beats -- consistent execution
− EPS declining -48.3% YoY despite any revenue growth
Technical Analyst
bullish
69
/ 100 · High confidence
Price action is constructive -- trend and momentum agree
+ Price structure making higher highs and higher lows
Macro Analyst
bullish
70
/ 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst
bullish
66
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.27 across 101 articles, 14d)
Portfolio Manager
neutral
45
/ 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 2535.03)
Investment Thesis Evolution
Committee score moved marginally from 54.5 to 57.0.
- Conviction changed from moderate to contested.
- Committee agreement fell notably from 67% to 50%.
- New bearish signals: 3 appeared.
- Bullish support removed: 1 signal(s) disappeared.
- New bullish signals: 1 appeared.
- Bearish pressure eased: 3 signal(s) disappeared.
- Analyst(s) changed stance: Macro Analyst.
Analyst-level changes:
- Macro Analyst: stance neutral->bullish; score 58->70 (+12).
- News Analyst: +1 bullish signal(s).
- Portfolio Manager: +2 bearish signal(s).
- Value Analyst: +1 bearish signal(s).
Comparing 2026-07-31 to 2026-08-01 (1 day apart).
Technical Analysis
RSI (14)
58.9
Neutral
MACD Histogram
0.096
Bullish Momentum
Trend Direction
Uptrend
Weekly: Uptrend
Market Structure
Hh Hl
Bollinger %B
0.73
Inside Bands
Price vs Moving Averages
EMA 9
$129.53
Above
EMA 21
$127.48
Above
EMA 50
$123.81
Above
EMA 200
$112.93
Above
Fundamental Analysis
Valuation
43
Growth
56
Profitability
1
Financial Health
57
Cash Flow
37
Valuation
P/E Ratio
36.6×
P/B Ratio
7.02×
PEG Ratio
-0.76
Dividend Yield
0.03%
52W High
$135.05
52W Low
$77.53
Quality & Growth
ROE
34.7%
ROA
13.3%
Gross Margin
75.9%
Operating Margin
27.6%
Revenue Growth YoY
—
Debt / Equity
1.07
AI Fundamental Assessment
P/E ratio of 36.6 (rich relative to a 15-40x range); Price-to-book of 7.0x; PEG ratio of -0.8 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 0.3%; Return on assets of 0.1%; Net margin of 0.1%; Gross margin of 0.8%; Current ratio of 1.30 (tight short-term liquidity); Debt-to-equity of 1.07; Free cash flow margin of 0.8% (thin cash generation); Free cash flow per share is positive (5.71); Most recent quarter beat estimates by 16.0%; 4 consecutive earnings beats; EPS growth decelerating (-22.0% -> -161.2% QoQ); Analyst estimates falling over recent quarters
Get the Full MRK Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →